| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $98.3M | -3.3% |
| Cost of Revenue | $39.3M | -0.3% |
| Gross Profit | $59.0M | -5.2% |
| R&D Expense | $1.3M | +326.2% |
| SG&A Expense | $16.3M | +1.3% |
| Operating Income | $16.9M | -21.5% |
| Pre-tax Income | $19.3M | -18.5% |
| Income Tax | $4.7M | -18.2% |
| Net Income | $14.8M | -17.7% |
| EPS (Basic) | $1.47 | -17.4% |
| EPS (Diluted) | $1.47 | -17.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.2M | +3.0% |
| Accounts Receivable | $13.7M | -5.0% |
| Inventory | $13.4M | -8.0% |
| Current Assets | $83.0M | -0.7% |
| Total Assets | $105.0M | -0.9% |
| Current Liabilities | $16.0M | -8.5% |
| Total Liabilities | $20.9M | -7.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.2M | -17.7% |
| Capital Expenditures | $1.8M | -9.2% |
| Investing Cash Flow | -$1.8M | +9.2% |
| Financing Cash Flow | -$13.7M | -1.5% |
| Free Cash Flow | $15.4M | -18.6% |
| $84.2M |
| +1.3% |